BDB551510
CD184 Rat anti-Human, PE, Clone: 1D9, BD
Manufacturer: BD Biosciences
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | BDB551510-Each-of-1 | In Stock | ₹ 42,008.00 |
BDB551510 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 42,008.00
GST (18%): ₹ 7,561.44
Total Price: ₹ 49,569.44
Antigen
CD184
Classification
Monoclonal
Concentration
0.2mg/mL
Description
CXCR4, Fusin
Host Species
Rat
Purification Method
Affinity Purified
Regulatory Status
RUO
Primary or Secondary
Primary
Content And Storage
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Applications
Flow Cytometry
Clone
1D9
Conjugate
PE
Formulation
Aqueous buffered solution containing ≤0.09% sodium azide.
Immunogen
Human CXCR4 fusion protein
Quantity
0.2 mg
Research Discipline
Immunology
Target Species
Human
Isotype
IgG2a κ
Related Products
Description
- The monoclonal antibody 1D9 reacts with the human CD184 which is also known as CXC chemokine receptor, CXCR4
- CXCR4 (previously known as fusin, LESTR and HUMSTR), a seven-transmembrane, G-protein-coupled receptor, is the specific receptor for CXC chemokines, SDF-1/CXCL12
- CXCR4 was widely expressed by hematopoietic and non-hematopoietic cell types including PMN, monocytes, T cells, B cells, CD34+ progenitor cells, endothelial cells, neurons and astrocytes
- The human CXCR4 is used by T-tropic HIV-1 as a co-receptor for viral entry
- The human CXCR4 gene has been mapped to chromosome 2q21
- The immunogen used to generate 1D9 hybridoma was human CXCR4 fusion protein
- This antibody is routinely tested by flow cytometric analysis
- Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.